Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biochemistry and clinical applications of ribavirin.

× No keyword cloud information.

39 in total

1. Ribavirin treatment of viral pneumonitis in severe combined immunodeficiency disease.

Authors: E W Gelfand; D McCurdy; C P Rao; P J Middleton
Journal: Lancet Date: 1983-09-24 Impact factor: 79.321

2. Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin.

Authors: W C Koff; R D Pratt; J L Elm; C N Venkateshan; S B Halstead
Journal: Antimicrob Agents Chemother Date: 1983-07 Impact factor: 5.191

3. In vivo inhibition of respiratory syncytial virus by ribavirin.

Authors: J F Hruska; P E Morrow; S C Suffin; R G Douglas
Journal: Antimicrob Agents Chemother Date: 1982-01 Impact factor: 5.191

4. Ribavirin small-particle aerosol treatment of influenza.

Authors: V Knight; H W McClung; S Z Wilson; B K Waters; J M Quarles; R W Cameron; S E Greggs; J M Zerwas; R B Couch
Journal: Lancet Date: 1981-10-31 Impact factor: 79.321

5. Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances.

Authors: D F Smee; R W Sidwell; S M Clark; B B Barnett; R S Spendlove
Journal: Antimicrob Agents Chemother Date: 1981-10 Impact factor: 5.191

6. Lassa fever. Effective therapy with ribavirin.

Authors: J B McCormick; I J King; P A Webb; C L Scribner; R B Craven; K M Johnson; L H Elliott; R Belmont-Williams
Journal: N Engl J Med Date: 1986-01-02 Impact factor: 91.245

7. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.

Authors: C B Hall; J T McBride; E E Walsh; D M Bell; C L Gala; S Hildreth; L G Ten Eyck; W J Hall
Journal: N Engl J Med Date: 1983-06-16 Impact factor: 91.245

8. Ribavirin treatment of experimental respiratory syncytial viral infection. A controlled double-blind study in young adults.

Authors: C B Hall; E E Walsh; J F Hruska; R F Betts; W J Hall
Journal: JAMA Date: 1983-05-20 Impact factor: 56.272

9. Ribavirin aerosol treatment of influenza B virus infection.

Authors: H W McClung; V Knight; B E Gilbert; S Z Wilson; J M Quarles; G W Divine
Journal: JAMA Date: 1983-05-20 Impact factor: 56.272

10. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants.

Authors: L H Taber; V Knight; B E Gilbert; H W McClung; S Z Wilson; H J Norton; J M Thurson; W H Gordon; R L Atmar; W R Schlaudt
Journal: Pediatrics Date: 1983-11 Impact factor: 7.124

57 in total

1. Synthesis of new bis-1,2,4-triazole derivatives.

Authors: Olcay Bekircan; Hakan Bektas
Journal: Molecules Date: 2006-06-21 Impact factor: 4.411

2. Management of respiratory viral infections in hematopoietic cell transplant recipients.

Authors: Dimpy P Shah; Shashank S Ghantoji; Victor E Mulanovich; Ella J Ariza-Heredia; Roy F Chemaly
Journal: Am J Blood Res Date: 2012-11-25

3. Nasopharyngeal swabs and nasopharyngeal aspirates equally effective for the diagnosis of viral respiratory disease in hospitalized children.

Authors: H Frayha; S Castriciano; J Mahony; M Chernesky
Journal: J Clin Microbiol Date: 1989-06 Impact factor: 5.948

4. Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice.

Authors: B E Gilbert; P R Wyde; G Lopez-Berestein; S Z Wilson
Journal: Antimicrob Agents Chemother Date: 1994-02 Impact factor: 5.191

5. MegaRibavirin aerosol for the treatment of influenza A virus infections in mice.

Authors: Brian E Gilbert; Matthew T McLeay
Journal: Antiviral Res Date: 2008-02-04 Impact factor: 5.970

6. Characteristics of hepatitis C virus infection in HIV-infected people.

Authors: C L Cooper; A D Badley; J B Angel
Journal: Can J Infect Dis Date: 2001-05

7. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.

Authors: J Balzarini; E De Clercq
Journal: Biochem J Date: 1992-11-01 Impact factor: 3.857

8. Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus.

Authors: B E Gilbert; P R Wyde; S Z Wilson; R K Robins
Journal: Antimicrob Agents Chemother Date: 1991-07 Impact factor: 5.191

9. Analysis of ribavirin mutagenicity in human hepatitis C virus infection.

Authors: Stéphane Chevaliez; Rozenn Brillet; Ester Lázaro; Christophe Hézode; Jean-Michel Pawlotsky
Journal: J Virol Date: 2007-05-09 Impact factor: 5.103

10. Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.

Authors: Celia Perales; Rubén Agudo; Hector Tejero; Susanna C Manrubia; Esteban Domingo
Journal: PLoS Pathog Date: 2009-11-13 Impact factor: 6.823